查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年脑部和神经成像设备市场预测：按成像类型、程序、用途、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1371992

到 2030 年脑部和神经成像设备市场预测：按成像类型、程序、用途、最终用户和地区进行的全球分析

Brain and Neuroimaging Devices Market Forecasts to 2030 - Global Analysis By Imaging Type, Procedure, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球大脑和影像设备市场规模为 224 亿美元，预计在预测期内将以 7.1% 的年复合成长率增长，到 2030 年达到 362 亿美元。

大脑和影像设备是用于了解大脑的结构、功能和药理学并识别受神经病变影响的区域的医疗设备。医学影像领域（称为神经成像）重点关注大脑。除了识别疾病和评估大脑健康之外，神经影像学还研究大脑的功能。神经科学家可以使用大脑影像设备观察活体大脑的内部。

根据美国卫生研究院的数据，2020年神经退化性疾病的经费将达到40.21亿美元。

技术进步

技术进步提高了大脑和影像设备的功能和有效性。例如，功能性磁振造影（fMRI）和扩散张量影像（DTI）等高高解析度影像技术的引入提高了我们检查大脑解剖结构和功能的能力。此外，随着技术进步使扫描能够更快、更舒适地完成，市场持续成长。

昂贵的诊断影像设备

大脑和影像技术市场预计将受到影像成像设备高成本的影响。认知心理学和神经病学的脑机介面研究需要功能性磁振造影（fMRI）、正子断层扫描（PET）、脑电图（EEG）等高阶设备。然而，这些设备价格昂贵，并非所有医院和实验室都能负担得起，特别是在开发中国家。因此，影像影像系统的高成本限制了医院和诊断实验室的购买力，是脑部和影像设备市场的障碍。

个人化医疗与精准影像诊断

个人化医疗的目标是修改医疗照护以适应患者的独特特征，例如大脑结构和功能。影像技术在提供个人化资讯以更好地制定治疗计划和监测神经系统疾病方面非常有用。此外，正在开发包括功能连接映射和多模态影像整合的精密影像方法，以寻找患者特异性生物标记并改善治疗结果，从而扩大市场。

法规挑战

大脑和神经影像设备市场受到欧洲药品管理局 (EMA) 和美国食品药物管理局(FDA) 等法规机构的严格规定和批准。此外，获得法规的批准以及新影像技术和设备的核准可能既耗时又昂贵。该领域的公司在遵守不断变化的法规规范和标准方面面临挑战。这些法规挑战正在阻碍市场成长。

COVID-19 的影响

COVID-19 的爆发对影像设备市场和领域产生了多种影响。随着医疗保健专业人员试图准确了解病毒如何影响大脑和相关的神经系统症状，MRI 和 CT 扫描等影像工具的使用在临床实践中增加。因此，对这些设备和相关技术的需求不断增加。疫情爆发推迟了医疗设备（特别是影像设备）的生产和分销，并扰乱了供应链。

门诊手术中心部分预计将在预测期内成为最大的部分

门诊手术中心部分估计占最大份额。在大脑和影像设备市场中，门诊手术中心（ASC）领域对于神经系统疾病的诊断和治疗尤其重要。这些设施经常作为各种医疗干预的门诊病人设施，例如神经外科和介入放射学手术，而影像技术是重要的设备。随着医疗保健系统优先考虑门诊病人护理和微创手术，影像设备将继续对 ASC 内的诊断和治疗途径至关重要。

预计脑血氧仪领域在预测期内年复合成长率最高

脑血氧计领域预计在预测期内将出现良好的成长。脑血氧计专门用于检测和评估脑氧浓度水平，是大脑和神经成像设备行业不可或缺的一部分。这些工具，包括近红外线光谱 (NIRS) 系统，对于非侵入性检测脑组织中的氧饱和度并为评估脑部健康提供关键资讯至关重要。这些设备越来越多地用于各种医疗环境，包括手术室、新生儿护理室和实验室，以提供有关大脑健康的深入资讯。

比最大的地区

由于先进的医疗基础设施、大量的研发投资以及神经系统疾病的高患病，亚太地区在估计期间占据了最大的市场占有率。北美拥有庞大的医院、诊所和研究设施网络，是世界上最先进的医疗基础设施之一。该基础设施促进了影像技术的获取和使用，以用于研究和临床诊断。许多神经损伤、多发性硬化症、阿兹海默症、帕金森氏症等疾病在该地区相对常见。

复合年复合成长率最高的地区：

预计欧洲在预测期内将出现盈利成长。欧洲的特点是强大的医疗保健系统、尖端的医疗技术以及对神经系统疾病日益浓厚的兴趣。由现代化医院、诊所和研究设施组成的网路是欧洲完善且广泛的医疗保健基础设施的一部分。该基础设施鼓励在临床诊断和学术研究中引入和使用影像技术。这种高患病增加了对改进影像技术以进行早期诊断、疾病监测和研究的需求。在许多欧洲国家，由于有利的支付法规，影像模式正变得越来越广泛地为患者和医疗保健专业人员所使用。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球大脑与神经影像设备市场：按影像类型

  • CT检查
  • 功能性磁振造影
  • 正子断层扫描
  • 脑电图测试
  • 近红外线光谱
  • 脑磁图
  • 颅内压监测仪
  • 脑血氧计
  • 睡眠监测装置
  • 肌电图检查装置
  • 其他影像处理类型

第6章全球大脑与影像设备市场：逐步实施

  • 侵入性的
  • 非侵入性

第7章全球大脑与影像设备市场：按应用

  • 创伤性脑损伤
  • 失智症
  • 帕金森氏症
  • 睡眠失调
  • 癫痫
  • 亨丁顿舞蹈症
  • 头痛症
  • 其他用途

第8章全球大脑和影像设备市场：按最终用户分类

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 诊所

第9章全球大脑和影像设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Canon
  • Hitachi Medical Systems
  • General Electric Company
  • Philips
  • Varian Medical Systems
  • Siemens
  • Toshiba Medical Systems
  • NeuroSoft
  • Sanrad Medical Systems Pvt. Ltd
  • Esaote SpA
  • Medtronic Plc
  • Elekta AB
  • Natus Medical Incorporated
  • Magstim Company Ltd.
  • Compumedics Limited
  • Brainlab AG
Product Code: SMRC24048

According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 billion in 2023 and is expected to reach $36.2 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The area of medical imaging known as neuroimaging focuses on the brain. Neuroimaging investigates how the brain functions in addition to identifying diseases and evaluating brain health. Neuroscientists can view the interior of the living brain using brain imaging devices.

According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020.

Market Dynamics:

Driver:

Technology advancements

Technology advancements have increased the functionality and effectiveness of brain and neuroimaging device. The ability to investigate brain anatomy and function, for instance, has improved with the introduction of high-resolution imaging techniques like functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI). Additionally, as a result of technological advancements, the market is still growing since they make it possible for scans to be completed more quickly and with more patient comfort.

Restraint:

High cost of imaging equipment

The market for brain and neuroimaging technologies is predicted to suffer from the high cost of imaging equipment. High-end equipment is needed for brain-computer interface research in cognitive psychology and neurology, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG). However, these are expensive devices that not all hospitals and laboratories, particularly in developing nations, can afford. Therefore, the high cost of imaging systems, which limits the purchasing power of hospitals and diagnostic labs, is a barrier to the market for brain and neuroimaging devices.

Opportunity:

Personalized medicine and precision imaging

The objective of personalised medicine is to modify medical care in accordance with a patient's particular traits, including their particular brain structure and function. Neuroimaging technology can be quite useful in delivering individualised information for better treatment planning and neurological condition monitoring. Furthermore, in order to find patient-specific biomarkers and improve treatment outcomes, precision imaging approaches, including functional connectivity mapping and multimodal imaging integration, are being developed, which expands the market.

Threat:

Regulatory challenges

The market for brain and neuroimaging devices is subject to strict rules and authorization from regulatory agencies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Additionally, it might take time and money to obtain regulatory clearance or approval for new imaging technologies or devices. Companies in this area face difficulties adhering to evolving regulatory norms and criteria. These regulatory challenges hinder market growth.

COVID-19 Impact

The COVID-19 epidemic has had a wide range of effects on the market and the field of neuroimaging devices. The use of neuroimaging tools like MRI and CT scans in clinical settings increased as medical practitioners sought to comprehend exactly the virus affected the brain and the associated neurological symptoms. The demand for these gadgets and associated technologies increased as a result. The epidemic delayed the production and distribution of medical equipment, especially neuroimaging devices, and interrupted supply networks.

The ambulatory surgical centers segment is expected to be the largest during the forecast period

The ambulatory surgical centers segment is estimated to hold the largest share. In the market for brain and neuroimaging devices, the Ambulatory Surgical Centres (ASCs) segment is particularly important for the diagnosis and management of neurological diseases. These facilities frequently act as outpatient settings for a variety of medical interventions, such as neurosurgery and interventional radiological procedures, where neuroimaging technologies are crucial instruments. Neuroimaging equipment will continue to be crucial to the diagnostic and therapeutic pathways within ASCs as healthcare systems prioritise outpatient care and minimally invasive procedures.

The cerebral oximeters segment is expected to have the highest CAGR during the forecast period

The cerebral oximeters segment is anticipated to have lucrative growth during the forecast period. The Cerebral Oximeters, which specialises in measuring and evaluating cerebral oxygenation levels, is an essential part of the brain and neuroimaging devices industry. These tools, including near-infrared spectroscopy (NIRS) systems, are essential for non-invasively detecting the oxygen saturation levels in the brain's tissues and delivering significant information for evaluating cerebral health. In a variety of medical settings, such as operating rooms, neonatal care units, and research labs, these devices are increasingly used because they provide insightful information on brain health.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of neurological disorders. With a vast network of hospitals, clinics, and research facilities, North America has one of the most sophisticated healthcare infrastructures in the world. This infrastructure makes it easier to acquire and use neuroimaging technology for both research and clinical diagnosis. Numerous neurological injuries, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and other conditions are relatively common in this region.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe is characterised by a strong healthcare system, cutting-edge medical technology, and a rising interest in neurological illnesses. A network of contemporary hospitals, clinics, and research facilities is part of Europe's established and extensive healthcare infrastructure. This infrastructure encourages the adoption and use of neuroimaging technology for clinical diagnosis and academic study. For early diagnosis, disease monitoring, and research, this high disease prevalence increases the need for improved neuroimaging technologies. Neuroimaging methods are more widely available to patients and medical professionals in many European nations thanks to favourable payment regulations.

Key players in the market:

Some of the key players in the Brain and Neuroimaging Devices Market include: Canon, Hitachi Medical Systems, General Electric Company, Philips, Varian Medical Systems, Siemens, Toshiba Medical Systems, NeuroSoft, Sanrad Medical Systems Pvt. Ltd, Esaote SpA, Medtronic Plc, Elekta AB, Natus Medical Incorporated, Magstim Company Ltd., Compumedics Limited and Brainlab AG.

Key Developments:

In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure.

In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon may participate in clinical and technical research programs, product evaluation projects, and consultations with Varian under this agreement to provide clinical expertise and industry perspectives throughout product development.

Imaging Types Covered:

  • Computed Tomography
  • Functional Magnetic Resonance Imaging
  • Positron Emission Tomography
  • Electroencephalography
  • Near Infrared Spectroscopy
  • Magneto encephalography
  • Intracranial Pressure Monitors
  • Cerebral Oximeters
  • Sleep Monitoring Devices
  • Electromyography Devices
  • Other Imaging Types

Procedures Covered:

  • Invasive
  • Non-Invasive

Applications Covered:

  • Traumatic Brain Injury
  • Dementia
  • Parkinson's Disease
  • Sleep Disorders
  • Epilepsy
  • Huntington's Disease
  • Headache Disorders
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Hospitals
  • Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain and Neuroimaging Devices Market, By Imaging Type

  • 5.1 Introduction
  • 5.2 Computed Tomography
  • 5.3 Functional Magnetic Resonance Imaging
  • 5.4 Positron Emission Tomography
  • 5.5 Electroencephalography
  • 5.6 Near Infrared Spectroscopy
  • 5.7 Magnetoencephalography
  • 5.8 Intracranial Pressure Monitors
  • 5.9 Cerebral Oximeters
  • 5.10 Sleep Monitoring Devices
  • 5.11 Electromyography Devices
  • 5.12 Other Imaging Types

6 Global Brain and Neuroimaging Devices Market, By Procedure

  • 6.1 Introduction
  • 6.2 Invasive
  • 6.3 Non-Invasive

7 Global Brain and Neuroimaging Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Traumatic Brain Injury
  • 7.3 Dementia
  • 7.4 Parkinson's Disease
  • 7.5 Sleep Disorders
  • 7.6 Epilepsy
  • 7.7 Huntington's Disease
  • 7.8 Headache Disorders
  • 7.9 Other Applications

8 Global Brain and Neuroimaging Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Diagnostic Centers
  • 8.4 Hospitals
  • 8.5 Clinics

9 Global Brain and Neuroimaging Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Canon
  • 11.2 Hitachi Medical Systems
  • 11.3 General Electric Company
  • 11.4 Philips
  • 11.5 Varian Medical Systems
  • 11.6 Siemens
  • 11.7 Toshiba Medical Systems
  • 11.8 NeuroSoft
  • 11.9 Sanrad Medical Systems Pvt. Ltd
  • 11.10 Esaote SpA
  • 11.11 Medtronic Plc
  • 11.12 Elekta AB
  • 11.13 Natus Medical Incorporated
  • 11.14 Magstim Company Ltd.
  • 11.15 Compumedics Limited
  • 11.16 Brainlab AG

List of Tables

  • Table 1 Global Brain and Neuroimaging Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 3 Global Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 4 Global Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 5 Global Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 6 Global Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 7 Global Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 8 Global Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 9 Global Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 10 Global Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 11 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 12 Global Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)

Table Global Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)

  • Table 13 Global Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 14 Global Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 15 Global Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 16 Global Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 18 Global Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 19 Global Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 20 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 21 Global Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 22 Global Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 23 Global Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 24 Global Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Global Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 27 Global Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 28 Global Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 29 Global Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 30 North America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 31 North America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 32 North America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 33 North America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 34 North America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 35 North America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 36 North America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 37 North America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 38 North America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 39 North America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 40 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 41 North America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 42 North America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 43 North America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 44 North America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 45 North America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 46 North America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 47 North America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 48 North America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 49 North America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 50 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 51 North America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 52 North America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 53 North America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 54 North America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 55 North America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 56 North America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 57 North America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 North America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 59 North America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 60 Europe Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 61 Europe Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 62 Europe Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 63 Europe Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 64 Europe Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 65 Europe Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 66 Europe Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 67 Europe Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 68 Europe Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 69 Europe Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 70 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 71 Europe Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 72 Europe Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 73 Europe Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 74 Europe Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 75 Europe Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 76 Europe Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Europe Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 78 Europe Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 79 Europe Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 80 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 81 Europe Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 82 Europe Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 83 Europe Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 84 Europe Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 85 Europe Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Europe Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 87 Europe Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 88 Europe Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 89 Europe Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 90 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 91 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 92 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 93 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 94 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 95 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 96 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 97 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 98 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 99 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 100 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 101 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 102 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 103 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 104 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 105 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 106 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 108 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 109 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 110 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 111 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 112 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 113 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 114 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 115 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 116 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 117 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 118 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 119 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 120 South America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 121 South America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 122 South America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 123 South America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 124 South America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 125 South America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 126 South America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 127 South America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 128 South America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 129 South America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 130 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 131 South America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 132 South America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 133 South America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 134 South America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 135 South America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 136 South America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 137 South America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 138 South America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 139 South America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 140 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 141 South America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 142 South America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 143 South America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 144 South America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 145 South America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 146 South America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 147 South America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 148 South America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 149 South America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 150 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 151 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 152 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 153 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 154 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 155 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 156 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 157 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 158 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 159 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 160 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 161 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 162 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 163 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 164 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 165 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 166 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 167 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 168 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 169 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 170 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 171 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 172 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 173 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 174 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 175 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 176 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 177 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 178 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 179 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)